Luminex Teams With Merck For Alzheimer’s Companion Diagnostic
The assay will be used to support patient selection as part of Merck’s ongoing clinical trial program for the MK-8931 Alzheimer’s disease drug candidate.
The assay will be used to support patient selection as part of Merck’s ongoing clinical trial program for the MK-8931 Alzheimer’s disease drug candidate.